XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity

Stock Option Activity

 

 

 

Outstanding
Stock Options

 

 

Weighted-
Average
Exercise
Price Per
Share

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

 

 

(in thousands, except per share amounts and years)

 

Outstanding as of December 31, 2023

 

 

13,783

 

 

$

6.39

 

 

 

8.7

 

 

$

146,966

 

Granted

 

 

2,841

 

 

 

17.43

 

 

 

 

 

 

 

Exercised

 

 

(525

)

 

 

3.51

 

 

 

 

 

 

 

Canceled and forfeited

 

 

(884

)

 

 

5.93

 

 

 

 

 

 

 

Expired

 

 

(85

)

 

 

3.37

 

 

 

 

 

 

 

Outstanding as of March 31, 2024

 

 

15,130

 

 

$

8.60

 

 

 

8.8

 

 

$

90,736

 

Vested as of March 31, 2024

 

 

3,667

 

 

$

4.43

 

 

 

7.6

 

 

$

34,256

 

Exercisable as of March 31, 2024

 

 

3,659

 

 

$

4.44

 

 

 

7.6

 

 

$

34,145

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s restricted stock activity:

 

 

 

Shares of
Restricted
Common
Stock

 

 

Weighted-
Average
Grant Date
Fair Value
Per Share

 

 

Shares of
Restricted
Stock
Units

 

 

Weighted-
Average Grant
Date Fair
Value Per
Share

 

 

 

(in thousands, except per share amounts)

 

Outstanding and unvested as of December 31, 2023

 

 

840

 

 

$

6.11

 

 

 

353

 

 

$

17.00

 

Granted

 

 

 

 

 

 

 

1,165

 

 

 

18.07

 

Vested

 

 

(190

)

 

 

0.26

 

 

 

 

 

Forfeited and canceled

 

 

 

 

 

 

 

(10

)

 

 

18.07

 

Outstanding and unvested as of March 31, 2024

 

 

650

 

 

$

7.81

 

 

 

1,508

 

 

$

17.83

 

 

Summary of Stock-Based Compensation Expense Recognized

The following table summarizes total stock-based compensation included in the Company’s condensed consolidated statements of operations and comprehensive loss:

 

 

 

Three Months Ended March 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Research and development

 

$

2,812

 

 

$

1,403

 

General and administrative

 

 

4,561

 

 

 

792

 

Total stock-based compensation

 

$

7,373

 

 

$

2,195